Large Investors Accelerate Medical Device Recalls
Institutional ownership leads to faster removal of risky products from the market.
1Risks of Recall Delays
Late detection of critical defects in medical devices prolongs patient risk and damages company reputations. Analysis of 2,932 recalls across 69 firms (2002-2020) reveals delays as a persistent issue in the healthcare sector.
2Institutional Investors' Oversight
A 1% increase in large institutional ownership correlates with 24 fewer days to recall. Investors actively monitor management, prompting quicker corrective actions for defective products.
3R&D Intensity as Moderator
The positive effect weakens in firms with high R&D expenditures. Complex product portfolios complicate oversight mechanisms and slow decision-making processes.
4High-Risk Devices Show Different Patterns
For life-critical devices like pacemakers, investor influence is less pronounced. Strict regulations and legal risks already compel all stakeholders to act swiftly.
5Policy Implications
Regulators should consider this beneficial investor role in operational decisions. Transparency-enhancing policies could strengthen monitoring and improve patient safety outcomes.
6Shifting Industry Paradigms
Findings reveal institutional investors shape not just financials but operational choices. An 'active investor' model in healthcare may balance patient and shareholder interests effectively.